Updates on mesenchymal stem cell therapies for articular cartilage regeneration in large animal models

Timothy P Liu1, Pin Ha1,2, Crystal Y Xiao3

  • 1Department of Orthopaedic Surgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States.

Insights

Mesenchymal stem cells (MSCs) show promise for cartilage regeneration in osteoarthritis. Large animal models are crucial for studying MSC therapies, but standardized protocols are needed for clinical translation.

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Orthopedics

Background:

  • Articular cartilage regeneration requires novel therapeutics for osteoarthritis and trauma.
  • Mesenchymal stem cells (MSCs) offer potential due to their chondrogenic and immunomodulatory properties.
  • Clinical application of MSCs necessitates further validation in translatable models.

Purpose of the Study:

  • To review the use of large animal models for mesenchymal stem cell (MSC)-based cartilage regeneration.
  • To discuss considerations for MSC source tissues and organisms in large animal studies.
  • To explore tissue engineering strategies for optimizing MSC therapies in preclinical settings.

Main Methods:

  • Focused review of research on MSCs for cartilage regeneration in large animal models (last 5 years).
  • Analysis of considerations for different large animal models (canine, porcine, ruminant, equine).
  • Evaluation of MSC source tissues, organisms, and tissue engineering strategies.

Main Results:

  • Large animal models provide a human-like osteochondral environment for evaluating allogeneic and xenogeneic human MSCs.
  • Specific considerations exist for utilizing each large animal model in MSC studies.
  • Tissue engineering strategies are being developed to enhance MSC efficacy.

Conclusions:

  • Large animal models are vital for advancing MSC-based cartilage regeneration towards clinical use.
  • Standardized assessment protocols are lacking, hindering the translatability of MSC findings.
  • Further research is needed to optimize MSC therapies and establish robust evaluation methods.